Delcath Systems News

Cancer treatment advances over the last decade have been phenomenal with great success in fighting a host of different cancers.

Keep track of the stocks that matter to you. Help yourself with the Fool's FREE and easy new watchlist service today.

Delcath Systems, Inc. A : Delcath Systems is at 13.333M shares, and Spot Secondary is $1.50. For the offering, Cowen and Wedbush behaved as joint book running managers.

In trading on Friday, medical instruments & supplies shares were relative laggards, down on the day by about 0.6%. Helping drag down the group were shares of Delcath Systems , off about 35.7% and shares of Navidea Biopharmaceuticals off about 1.8% on the day.

Volunteers can enjoy Southwest Michigan state parks while protecting... US-2 resurfacing east of Rapid River begins May... MDOT to open temporary ramp off I-94/I-69 for Water Street businesses in... Residential Mortgage-Backed Securities Working Group Announces New... MDOT to hold public meeting on I-275/M-153 area study in Wayne... Repair to ... (more)

NEW YORK, May 8, 2012 /PRNewswire/ -- Delcath Systems today announced financial results and highlights for its first quarter 2012 ended March 31, 2012 and recent weeks.